FDA “Listed Drug” Definition For ANDA “Bundling” Should Maintain Current Flexibility – GPhA
This article was originally published in The Pink Sheet Daily
Executive Summary
Generic Pharmaceutical Association says forthcoming agency guidance should embody current practices, which allow ANDA filers to “bundle” different variations of generic products into one application.